Spring transfer portal is just around the corner, and trouble has already befallen Mario Cristobal. The post Double Blow for ...

No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ: VKTX), the turbulence has been extremely challenging thus far. The stock ...